July 6, 2023 Worldwide collaborative framework for optimizing new Parkinson’s treatment trials with patient centric outcome measures
September 24, 2021 Critical Path for Parkinson’s Consortium 3DT Initiative: Recommendations for involving people with Parkinson’s in clinical studies using digital health tools Recommendations for involving people with Parkinson’s in clinical studies using digital health tools
April 27, 2020 Critical Path for Parkinson’s Consortium 3DT Initiative: Early regulatory engagement to optimize paths for efficient use of digital health technologies in PD clinical trials
September 23, 2019 Enabling efficient use of digital health technologies to support Parkinson’s disease drug development through precompetitive collaboration
June 3, 2019 Collaborative framework for delivering on ways that digital technologies can help to optimize new Parkinson’s treatment trials. Stephenson D …et al. | 5th World Parkinson Congress, Kyoto, Japan
May 1, 2019 Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science. Stephenson D …et al. | American Academy of Neurology, Philadelphia, PA
March 17, 2019 Increasing Efficiency, Safety, and Speed in Clinical Trials for Neurodegenerative Diseases | Alzheimer’s Drug Discovery Foundation Conference, Long Beach, CA
February 19, 2019 Delving into the Role of Public Private Partnerships in Shaping the Landscape to Enable Precision Medicine for Neurodegeneration | 7th World CNS Summit, Boston, MA